Brief: Cansino Biologics Says 9M Operating Revenue RMB567.1 Million
29/10/2024 09:35
Oct 29 (Reuters) - CanSino Biologics Inc 688185.SS :
* 9M OPERATING REVENUE RMB567.1 MILLION
* 9M NET LOSS ATTRIBUTABLE RMB222.4 MLN
Further company coverage: 688185.SS
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025